What is the cumulative number of patients who have received health support information through 'enpas'?

As of March 2026, we have surpassed a cumulative total of 10 million patients.

What specific tasks does 'enpas' streamline?

'enpas' automates and visualizes the preparation of guidance sheets and checklists according to prescriptions, information provision to hospitals, and the process for claiming specific drug management and guidance fees, thereby reducing the administrative workload for pharmacists.

How does 'enpas' help with the 2026 dispensing fee revision?

As the evaluation of interpersonal services becomes stricter, 'enpas' contributes to the stabilization of pharmacy management by systematizing high-quality interventions and supporting the acquisition of additional fees.

Are there specific effects from introducing 'enpas'?

There are cases where information provided to medical institutions has increased approximately fivefold, and material preparation time has been reduced by about 10 minutes per prescription. Furthermore, improvements in medication adherence and increased repeat visits due to becoming a community pharmacy are also expected.

AI News NQ Analysis

Pharmacy DX Solution 'enpas' Surpasses 10 Million Patients Receiving Health Support Information, Enhancing Support for Additional Fees and Operational Efficiency in Preparation for the 2026 Dispensing Fee Revision

NQ Score 84/100

N1 Content Completeness 90

AI Summary (NQ-processed)

Pharmacy DX 'enpas' exceeds 10 million patients receiving health support information, strengthening its response to dispensing fee revisions.

AI Analysis

What It Means

調剤報酬改定による対人業務評価の厳格化に対し、DXによる業務効率化と実績の可視化で薬局経営を支援する動き。

Industry Implication

薬局業界において、単なる調剤から「患者への介入実績」を証明するDXツールへの投資が加速する。

Competitive Landscape

同様の薬局向けDXツールとの差別化として、具体的な加算獲得実績と業務効率化の数値的エビデンスが重要視される。

Market Signal

2026年の調剤報酬改定に向け、薬局経営の「対人業務シフト」が本格化している。

Prediction

他社DXツールとの機能統合や、加算算定を自動化するAI機能の高度化が進む。

Frequently Asked Questions

Q: What is the cumulative number of patients who have received health support information through 'enpas'?: A: As of March 2026, we have surpassed a cumulative total of 10 million patients.
Q: What specific tasks does 'enpas' streamline?: A: 'enpas' automates and visualizes the preparation of guidance sheets and checklists according to prescriptions, information provision to hospitals, and the process for claiming specific drug management and guidance fees, thereby reducing the administrative workload for pharmacists.
Q: How does 'enpas' help with the 2026 dispensing fee revision?: A: As the evaluation of interpersonal services becomes stricter, 'enpas' contributes to the stabilization of pharmacy management by systematizing high-quality interventions and supporting the acquisition of additional fees.
Q: Are there specific effects from introducing 'enpas'?: A: There are cases where information provided to medical institutions has increased approximately fivefold, and material preparation time has been reduced by about 10 minutes per prescription. Furthermore, improvements in medication adherence and increased repeat visits due to becoming a community pharmacy are also expected.